Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (15094)	1/4/2005 4:12:41 PM
From: Arthur Radley	Read Replies (2) \| Respond to of 52153

With all this chatter about statins, does anyone have any idea about the safety profile for the new combined Zocor and Zetia drug? Currently I take both and I'm considering taking the combined pill...so any suggestions would be appreciated.

To: Biomaven who wrote (15094)	1/4/2005 6:03:52 PM
From: Stephen O	Read Replies (1) \| Respond to of 52153

That study focuses on people who already have CHD. I was pointing out that using statins prophylacticaly just to reduce cholesterol does hardly anything to improve mortality. As for women Dr Golomb disagrees with you. ...benefit to survival with statins or other cholesterol-lowering agents has never been demonstrated in women (even those at high cardiac risk), in the older elderly, or in men at lower cardiac risk..." Dr. Beatrice A. Golomb, MD, PhD, Principal Investigator of ongoing National Institutes of Health study of statin side effects. Read full interview. statinalert.org